期刊文献+

阿尔茨海默病与维生素D水平的关系 被引量:5

Relationship between serum 25 (OH)D level and cognitive function in patients with Alzheimer's disease
原文传递
导出
摘要 目的,了解阿尔茨海默病(AD)患者体内维生素D营养状况,分析其血清25羟维生素D[25(OH)D ]水平与认知功能的关系,为临床补充维生素D制剂的干预研究提供依据。方法 回顾性分析本院113例住院AD患者血清总25(OH)D浓度与认知功能的关系。采用液相色谱-串联质谱法(LC-MS/MS),定量测定AD患者血清25(OH)D2、25(OH)D3 和总25(OH)D浓度。按2011年美国医学科学院(IOM)的维生素D营养状况分级标准分组:维生素D充足组[25(OH)D≥75 nmol/L]、维生素D不足组[25(OH)D 50~75 nmol/L]、维生素D缺乏组[25(OH)D 25~50 nmol/L]和维生素D严重缺乏组[25(OH)D≤25 nmol/L]。结果 (1)113例AD患者血清总25(OH)D为(27.08±15.33)nmol/L,其中血清25(OH)D2为(1.23±0.93)nmol/L和25(OH)D3为(24.50±13.04)nmol/L;(2)60.18 %(68/113)患者维生素D严重缺乏、30.97 %(35/113)患者维生素D缺乏、7.97%(9/113)患者维生素D不足和0.88%(1/113)患者维生素D充足;(3)AD患者血清总25(OH)D浓度与MMSE总分的Spearman秩和相关分析呈正相关关系(r=0.202,P=0.032)。结论 住院AD患者严重缺乏维生素D,需要补充维生素D;血清总25(OH)D浓度与认知功能有正相关关系;补充维生素D制剂是否能提高认知功能,需要进一步进行随机双盲、安慰剂对照临床研究证实。 Objective To explore the relationship between serum 25(OH)D level and cognitive function in patients with Alzheimer′s disease (AD). Methods Totally 113 AD impatients were enrolled in this study. Their serum 25(OH)D2, 25(OH)D3, and total 25(OH)D levels were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Patients were divided into Vitamin D severe deficiency group [25(OH)D level≤25 nmol/L], deficiency group[25(OH)D levels: 25-50 nmol/L], insufficiency group[25(OH)D level: 50-75 nmol/L], and sufficiency group[25(OH)D level ≥75 nmol/L] according to the criteria proposed by US Institute of Medicine. The cognitive function was assessed by MMSE score. The association between serum 25(OH)D level and cognitive function was systematically analyzed. Results The serum levels of 25(OH)D, 25(OH)D2, and 25(OH)D3 were(27.08±15.33)nmol/L, (1.23±0.93) nmol/L and (24.50±13.04) nmol/L in AD patients. The proportions of severe deficiency, deficiency, insufficiency, and sufficiency were 60.18%(68/113), 30.97%(35/113),7.97%(9/113),and 0.88%(1/113), respectively, among these AD patients. A positive correlation was found between serum 25(OH) D concentration and MMSE score in AD patients. Conclusions Impatients with AD often have severe vitamin D deficiency and need vitamin D supplementation. Serum 25(OH)D concentration is associated with cognitive function, and therefore vitamin D supplementation may improve cognitive function.
出处 《中华临床营养杂志》 CAS CSCD 2013年第3期143-146,共4页 Chinese Journal of Clinical Nutrition
关键词 阿尔茨海默病 维生素D 缺乏 25羟维生素D AIzheimer's disease Vitamin D Deficiency 25 (OH) D
  • 相关文献

参考文献18

  • 1鞠康,陈悦,周建烈.维生素D与阿尔茨海默病[J].中华临床营养杂志,2012,20(4):258-260. 被引量:7
  • 2Zhao Y, Sun Y, Ji HF, et al. Vitamin D levels in Alzheimer's and Parkinson's diseases : a meta-analysis [ J]. Nutrition, 2013, 29 (6): 828-832.
  • 3Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis [ J ]. J Alzheimem Dis, 2013, 33 ( 3 ) : 659-674.
  • 4Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician [J]. J Psychiatr Res, 1975, 12 (3) : 189-198.
  • 5American Psychiatric Association. Diagnostic and statistical man- ualof mental disorders [ M 1- 4 ed. Washington : American Psy- chiatricAssociation, 1994: 143-147.
  • 6McKhann G, Drachman D, Folstein M, et al. Clinical-diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease [ J ]. Neurology, 1984, 34 (7): 939-944.
  • 7周建烈,陈悦,余琛,李水军.血清25(OH)D测定的液相色谱质谱法[J].中华临床营养杂志,2011,19(5):339-342. 被引量:6
  • 8IOM ( Institute of Medicine). Dietary reference intakes for calci- um and vitamin D (2011) [M]. Washington DC: The National Academies Press, 2011.
  • 9Roth HI, Sehmidt-Gayk H, Weber H, et al. Accuracy and clin- ical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a refer- enee [J]. Ann Clin Biochem, 2008, 45 (Pt2) : 153-159.
  • 10Carter GD. 25-hydroxyvitamin D assays: the quest for accuracy [J]. Clin Chem, 2009, 55 (7) : 1300-1302.

二级参考文献14

  • 1Stein MS, Scherer SC, Ladd KS, et al. A randomized controlled trial of high-doze vitamin D2 followed by intranasal insulin in Alzheimer's disease [ J]. J Alzheimers Dis, 2011, 26(3) :477-484.
  • 2Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services [J]. Neurology, 2010, 74(1) :18-26.
  • 3Jyvakorpi SK, Puranen T, Pitkala KH, et al. Nutritional treatment of aged individuals with Alzheimer's disease living at home with their spouses: study protocol for a randomized controlled trial [J]. Trials, 2012, 13(1) :66.
  • 4Annweiler C, Fantino B, Parot-Schinkel E, et al. Alzheimer's dis- ease-input of vitamin D with mEmantine assay ( AD-IDEA trial) : study protocol for a randomized controlled trial [ J ]. Trials, 2011, 12:230.
  • 5Annweiler C, Beauchet O. Possibility of a new anti-Alzheimer's dis- ease pharmaceutical composition combining memantine and vitamin D [J]. Drugs Aging, 2012, 29(2) :81-91.
  • 6Lu'o'ng KV, Nguy6n LT. The beneficial role of vitamin D in Alzheimer's disease [ J]. Am J Alzheimers Dis Other Demen, 2011, 26(7) :511-520.
  • 7Annweiler C, Beanchet O. Vitamin D-mentia: randomized clinical trials should be the next step [ J]. Neuroepidemiology, 2011, 37 ( 3-4 ) : 249 -258.
  • 8Dickens AP, Lang IA, Langa KM, et al. Vitamin D, cognitive dys- function and dementia in older adults [J]. CNS Drugs, 2011, 25 (8) :629-639.
  • 9Nakagawa K. Effect of vitamin D on the nervous system and the skel- etal muscle [J]. Clin Calcium, 2006, 16(7) :1182-1187.
  • 10Annweiler C, Schott AM, Rolland Y, et al. Dietary intake of vita- min D and cognition in older women: a large population-based study [ J]. Neurology, 2010, 75 (20) : 1810-1816.

共引文献11

同被引文献30

  • 1陈悦,周建烈.维生素D缺乏的流行病学研究进展[J].中华临床营养杂志,2009,17(5). 被引量:29
  • 2Kojima G, Bell C, Abbott RD, et al. Low dietary vitamin D predicts 34 - year incident stroke : the Honolulu Heart Program [ J ]. Stroke,2012, 43 (8): 2163-2167.
  • 3Sun Q, Pan A, Hu FB, et al. 25 - Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta - analysis [ J ]. Stroke, 2012, 43 (6) : 1470-1477.
  • 4Zhao Y, Sun Y, Ji HF, et al. Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta- analysis [J]. Nutrition, 2013, 29 (6) : 828 - 832.
  • 5Annweiler C, Llewellyn DJ, Beanehet O, et al. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta -analysis [J]. J Alzheimers Dis, 2013, 33 (3): 659-674.
  • 6Annweiler C, Montero - Odasso M, Llewellyn DJ, et al. Meta - analysis of memory and executive dysfunctions in relation to vitamin D [J]. J Alzheimers Dis, 2013, 37 (1) : 147 -171.
  • 7Whitehouse AJ, Holt BJ, Serralha M, et al. Maternal serum vitamin D levels during pregnancy and offspring neuroeognitive development [J]. Pediatrics, 2012, 129 (3): 485-493.
  • 8Ding H, Dhinm K, Loekhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study [J]. Neurology, 2013, 81 (17) : 1531 -1537.
  • 9Keeney JT, Ffirster S; Sultana R, et al. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D - dependent age - related cognitive decline [J]. Free Radic Biol Med. 2013. 65, 324-334.
  • 10Crews M, Lally J, Gardner - Sood P, et al. Vitamin D deficiency in first episode psychosis : a case - control study [ J ]. Schizophr Res, 2013, 150 (2/3): 533-537.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部